KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
7.87
+0.43 (5.78%)
At close: Aug 13, 2025, 4:00 PM
7.77
-0.11 (-1.33%)
After-hours: Aug 13, 2025, 6:47 PM EDT
KALA BIO Employees
KALA BIO had 38 employees as of December 31, 2024. The number of employees decreased by 5 or -11.63% compared to the previous year.
Employees
38
Change (1Y)
-5
Growth (1Y)
-11.63%
Revenue / Employee
n/a
Profits / Employee
-$979,658
Market Cap
50.78M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
KALA News
- 5 days ago - KALA BIO Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 days ago - KALA BIO to Present at H.C. Wainwright 5th Annual Ophthalmology Virtual Conference - GlobeNewsWire
- 5 weeks ago - KALA BIO Announces Completion of Enrollment in CHASE Clinical Trial Evaluating KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED) - GlobeNewsWire
- 2 months ago - KALA BIO to Present at Jefferies Global Healthcare Conference - GlobeNewsWire
- 6 months ago - KALA BIO Announces Chief Executive Officer Transition - GlobeNewsWire
- 8 months ago - KALA BIO Announces $10,750,000 Private Placement - GlobeNewsWire
- 9 months ago - KALA BIO to Present at Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 1 year ago - KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire